Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilli

Abstract The growing prevalence of antibiotic resistance in multidrug-resistant Gram-negative bacteria (MDR-GNB), exacerbated by the misuse of antibiotics, presents a critical global health challenge. Colistin, a last-resort antibiotic for severe MDR-GNB infections, has faced diminishing efficacy du...

Full description

Saved in:
Bibliographic Details
Main Authors: Chawalit Chatupheeraphat, Noramon Kaewsai, Nuttapat Anuwongcharoen, Chuleeporn Phanus-umporn, Sudarat Pornsuwan, Warawan Eiamphungporn
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-01303-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849312114984878080
author Chawalit Chatupheeraphat
Noramon Kaewsai
Nuttapat Anuwongcharoen
Chuleeporn Phanus-umporn
Sudarat Pornsuwan
Warawan Eiamphungporn
author_facet Chawalit Chatupheeraphat
Noramon Kaewsai
Nuttapat Anuwongcharoen
Chuleeporn Phanus-umporn
Sudarat Pornsuwan
Warawan Eiamphungporn
author_sort Chawalit Chatupheeraphat
collection DOAJ
description Abstract The growing prevalence of antibiotic resistance in multidrug-resistant Gram-negative bacteria (MDR-GNB), exacerbated by the misuse of antibiotics, presents a critical global health challenge. Colistin, a last-resort antibiotic for severe MDR-GNB infections, has faced diminishing efficacy due to the emergence of colistin-resistant (COL-R) strains. This study evaluates the potential of penfluridol (PF), an antipsychotic drug with notable antibacterial and antibiofilm properties, to restore colistin activity against COL-R GNB in vitro. PF alone exhibited limited antibacterial activity against COL-R GNB; however, its combination with colistin demonstrated strong synergistic effects, significantly reducing colistin’s minimum inhibitory concentrations (MICs) by 4-128 times. Time-kill assays confirmed the combination’s superior bactericidal activity compared to either agent alone. Membrane permeability assays revealed that PF enhanced colistin’s ability to disrupt bacterial membranes, likely by facilitating colistin binding to lipopolysaccharide. Furthermore, PF significantly inhibited the development of colistin resistance over a 30-day resistance development assay. In addition to its antibacterial effects, PF exhibited notable antibiofilm activity. The combination of PF and colistin effectively inhibited biofilm formation and eradicated mature biofilms in most of the tested COL-R GNB strains. These findings mark the first report of PF’s synergistic interaction with colistin against GNB biofilms, offering a promising strategy to combat biofilm-associated infections. Overall, the colistin/PF combination holds potential as an effective therapeutic strategy to enhance colistin efficacy, delay resistance development, and manage biofilm-associated infections in MDR-GNB.
format Article
id doaj-art-654ad5d7d31442d1984890e7706a99bc
institution Kabale University
issn 2045-2322
language English
publishDate 2025-05-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-654ad5d7d31442d1984890e7706a99bc2025-08-20T03:53:12ZengNature PortfolioScientific Reports2045-23222025-05-0115111310.1038/s41598-025-01303-9Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilliChawalit Chatupheeraphat0Noramon Kaewsai1Nuttapat Anuwongcharoen2Chuleeporn Phanus-umporn3Sudarat Pornsuwan4Warawan Eiamphungporn5Center for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol UniversityCenter for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol UniversityDepartment of Community Medical Technology, Faculty of Medical Technology, Mahidol UniversityDepartment of Community Medical Technology, Faculty of Medical Technology, Mahidol UniversityInternational Center for Medical and Radiological Technology, Faculty of Medical Technology, Mahidol UniversityDepartment of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol UniversityAbstract The growing prevalence of antibiotic resistance in multidrug-resistant Gram-negative bacteria (MDR-GNB), exacerbated by the misuse of antibiotics, presents a critical global health challenge. Colistin, a last-resort antibiotic for severe MDR-GNB infections, has faced diminishing efficacy due to the emergence of colistin-resistant (COL-R) strains. This study evaluates the potential of penfluridol (PF), an antipsychotic drug with notable antibacterial and antibiofilm properties, to restore colistin activity against COL-R GNB in vitro. PF alone exhibited limited antibacterial activity against COL-R GNB; however, its combination with colistin demonstrated strong synergistic effects, significantly reducing colistin’s minimum inhibitory concentrations (MICs) by 4-128 times. Time-kill assays confirmed the combination’s superior bactericidal activity compared to either agent alone. Membrane permeability assays revealed that PF enhanced colistin’s ability to disrupt bacterial membranes, likely by facilitating colistin binding to lipopolysaccharide. Furthermore, PF significantly inhibited the development of colistin resistance over a 30-day resistance development assay. In addition to its antibacterial effects, PF exhibited notable antibiofilm activity. The combination of PF and colistin effectively inhibited biofilm formation and eradicated mature biofilms in most of the tested COL-R GNB strains. These findings mark the first report of PF’s synergistic interaction with colistin against GNB biofilms, offering a promising strategy to combat biofilm-associated infections. Overall, the colistin/PF combination holds potential as an effective therapeutic strategy to enhance colistin efficacy, delay resistance development, and manage biofilm-associated infections in MDR-GNB.https://doi.org/10.1038/s41598-025-01303-9Gram-negative bacteriaColistin resistanceSynergistic effectPenfluridolAntibiofilmDrug repurposing
spellingShingle Chawalit Chatupheeraphat
Noramon Kaewsai
Nuttapat Anuwongcharoen
Chuleeporn Phanus-umporn
Sudarat Pornsuwan
Warawan Eiamphungporn
Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilli
Scientific Reports
Gram-negative bacteria
Colistin resistance
Synergistic effect
Penfluridol
Antibiofilm
Drug repurposing
title Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilli
title_full Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilli
title_fullStr Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilli
title_full_unstemmed Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilli
title_short Penfluridol synergizes with colistin to reverse colistin resistance in Gram-negative bacilli
title_sort penfluridol synergizes with colistin to reverse colistin resistance in gram negative bacilli
topic Gram-negative bacteria
Colistin resistance
Synergistic effect
Penfluridol
Antibiofilm
Drug repurposing
url https://doi.org/10.1038/s41598-025-01303-9
work_keys_str_mv AT chawalitchatupheeraphat penfluridolsynergizeswithcolistintoreversecolistinresistanceingramnegativebacilli
AT noramonkaewsai penfluridolsynergizeswithcolistintoreversecolistinresistanceingramnegativebacilli
AT nuttapatanuwongcharoen penfluridolsynergizeswithcolistintoreversecolistinresistanceingramnegativebacilli
AT chuleepornphanusumporn penfluridolsynergizeswithcolistintoreversecolistinresistanceingramnegativebacilli
AT sudaratpornsuwan penfluridolsynergizeswithcolistintoreversecolistinresistanceingramnegativebacilli
AT warawaneiamphungporn penfluridolsynergizeswithcolistintoreversecolistinresistanceingramnegativebacilli